There is a great deal of interest in the identification of biomarkers that are closely associated
with disease activity in systemic lupus erythematosus (SLE), but few biomarkers have been …

Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …

Managing patients with severe asthma during the coronavirus pandemic and COVID-19 is a
challenge. Authorities and physicians are still learning how COVID-19 affects people with …

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis
and/or asthma. Many guidelines or national practice guidelines have been produced but …

The World Allergy Organization (WAO) Guidelines for the assessment and management of
anaphylaxis provide a unique global perspective on this increasingly common, potentially life-…

The selection of pharmacotherapy for patients with allergic rhinitis aims to control the disease
and depends on many factors. Grading of Recommendations Assessment, Development …

Five biologicals have been approved for severe eosinophilic asthma, a well‐recognized
phenotype. Systematic reviews (SR) evaluated the efficacy and safety of benralizumab, …

NSAID ‐exacerbated respiratory disease (N‐ ERD ) is a chronic eosinophilic, inflammatory
disorder of the respiratory tract occurring in patients with asthma and/or chronic rhinosinusitis …

Urticaria and angioedema are common clinical conditions representing a major concern for
physicians and patients alike. The World Allergy Organization (WAO), recognizing the …

OBJECTIVE: Adult onset Still9s disease (AOSD) is a systemic inflammatory disorder characterized
by fever, arthritis, and rash. Although the pathogenesis is not known, immunologically …